Manar Alaa Mabrouk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manar Alaa Mabrouk has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah A. Helal
Faculty of Medicine, Fayoum University, Fayoum, Egypt
1 shared publication Abdelwahab Waleed Salah
1 shared publication- Ahmed Amir Samir
Faculty of Medicine, Al-Azhar University, Cairo, Egypt
1 shared publication - Ahmed Hatem Ibrahim
Faculty of Medicine, Tanta University, Tanta, Egypt
1 shared publication - Ahmed Hussein Elamir
Faculty of Medicine, Mansoura University, Dakahlia, Egypt
1 shared publication Ahmed Khaled Fathy
1 shared publication
Latest Publications
- Open Access
- 8 February 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-14
Sociodemographic, lifestyle, and psychological factors as controllable predictors of academic self-efficacy after reforming a medical education system; the Egyptian Nationwide experience
Academic self-efficacy (ASE), influenced by various sociodemographic, lifestyle, and psychological factors, is a critical determinant of academic performance in medical students. In Egypt, the medical education system underwent recent drastic changes. Therefore, we aim to explore the effects of these changes on the variables above and, subsequently, on ASE among a national sample of Egyptian medical students. We conducted a cross-sectional study across 30 Egyptian medical colleges using a validated electronic Arabic survey to evaluate sociodemographic, lifestyle behaviors, psychological factors, and ASE. Categorical variables were described using frequencies and percentages, while Continuous variables were summarized as mean and standard deviation. Bivariate analysis with post-hoc testing, Pearson’s correlation coefficient, and multivariate linear regression were employed to assess the associations between the study variables and ASE. Data analysis was performed using R Statistical Software. A total of 1446 participants were included, with a mean age of 20.59 ± 1.68. Of these, 61.5% (n = 890) were Females, while 94.3% (n = 1363) were single. ASE was significantly associated with certain financial status, smoking, sleeping hours, breakfast patterns, diet changes, and fluids. Stress, anxiety, and depression were associated with and correlated to poor ASE. Only depression, oversleeping, and smoking were significant predictors of worse ASE. Multiple variables are significantly associated with, correlated to, or predictors of ASE after the recent reform in the Egyptian medical education system. Subsequently, targeted interventions to specific sociodemographic, lifestyle, and psychological factors can be adopted and assessed through future longitudinal pre-post interventional studies.
- 8 February 2025
- Published by Springer Nature in BMC Medical Education
- Vol. 25 (1) , 1-14
Open AccessSociodemographic, lifestyle, and psychological factors as controllable predictors of academic self-efficacy after reforming a medical education system; the Egyptian Nationwide experience
Academic self-efficacy (ASE), influenced by various sociodemographic, lifestyle, and psychological factors, is a critical determinant of academic performance in medical students. In Egypt, the medical education system underwent recent drastic changes. Therefore, we aim to explore the effects of these changes on the variables above and, subsequently, on ASE among a national sample of Egyptian medical students. We conducted a cross-sectional study across 30 Egyptian medical colleges using a validated electronic Arabic survey to evaluate sociodemographic, lifestyle behaviors, psychological factors, and ASE. Categorical variables were described using frequencies and percentages, while Continuous variables were summarized as mean and standard deviation. Bivariate analysis with post-hoc testing, Pearson’s correlation coefficient, and multivariate linear regression were employed to assess the associations between the study variables and ASE. Data analysis was performed using R Statistical Software. A total of 1446 participants were included, with a mean age of 20.59 ± 1.68. Of these, 61.5% (n = 890) were Females, while 94.3% (n = 1363) were single. ASE was significantly associated with certain financial status, smoking, sleeping hours, breakfast patterns, diet changes, and fluids. Stress, anxiety, and depression were associated with and correlated to poor ASE. Only depression, oversleeping, and smoking were significant predictors of worse ASE. Multiple variables are significantly associated with, correlated to, or predictors of ASE after the recent reform in the Egyptian medical education system. Subsequently, targeted interventions to specific sociodemographic, lifestyle, and psychological factors can be adopted and assessed through future longitudinal pre-post interventional studies.
- Open Access
- 6 February 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-30
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
Background: Postpartum depression (PPD) is categorized by the Disorders-Fifth Edition as depression that begins during pregnancy or within the first month after giving birth. Ketamine and esketamine have shown promising results in the treatment of several depressive disorders, which suggests that they may have a role in the prevention of PPD. This systematic review and meta-analysis aim to update evidence about the efficacy and safety of using ketamine and esketamine to reduce PPD incidence. Methods: We searched four databases, PubMed, Scopus, Web of Science, and Cochrane, to collect relevant studies. We included studies which investigated the preventive effect of ketamine or esketamine on PPD among women after giving birth through caesarean or vaginal delivery. We extracted PPD occurrence rate, PPD score, pain score and side effects. Finally, a meta-analysis was conducted using RevMan software. Results: Twenty-one eligible studies were incorporated in the current systematic review and meta-analysis involving 4,389 pregnant women. Esketamine was the intervention in 14 studies, and ketamine was used in 7 studies. In subgroup analysis, both ketamine and esketamine were significantly effective in reducing the incidence of short-term PPD (ketamine: RR = 0.72, 95% CI [0.56, 0.93], P = 0.01; esketamine: RR = 0.43, P < 0.0001). Esketamine only significantly reduced the incidence of long-term PPD (RR = 0.44, P < 0.00001). Low doses and high doses were effective in reducing the incidence of both short-term (high dose: RR = 0.48, P = 0.0005; low dose: RR = 0.46, P = 0.002) and long-term PPD (high dose: RR = 0.54, P < 0.0001; low dose: RR = 0.61, P = 0.009). Regarding the risk of side effects, patients in the Ketamine/esketamine group showed statistically significant higher rates of developing dizziness (P = 0.0007), blurred vision (P = 0.02), vomiting (P = 0.004) and hallucinations (P = 0,002) than women in the control group. Conclusion: Both ketamine and esketamine are effective in lowering the incidence of short-term PPD. On the other hand, only esketamine is effective in reducing the incidence of long-term PPD. It is recommended to use smaller doses for a more tolerable treatment period since doses less than 0.5 mg are significantly effective. Temporary side effects such as dizziness, blurred vision, vomiting and hallucinations were reported.
- 6 February 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-30
Open AccessEfficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
Background: Postpartum depression (PPD) is categorized by the Disorders-Fifth Edition as depression that begins during pregnancy or within the first month after giving birth. Ketamine and esketamine have shown promising results in the treatment of several depressive disorders, which suggests that they may have a role in the prevention of PPD. This systematic review and meta-analysis aim to update evidence about the efficacy and safety of using ketamine and esketamine to reduce PPD incidence. Methods: We searched four databases, PubMed, Scopus, Web of Science, and Cochrane, to collect relevant studies. We included studies which investigated the preventive effect of ketamine or esketamine on PPD among women after giving birth through caesarean or vaginal delivery. We extracted PPD occurrence rate, PPD score, pain score and side effects. Finally, a meta-analysis was conducted using RevMan software. Results: Twenty-one eligible studies were incorporated in the current systematic review and meta-analysis involving 4,389 pregnant women. Esketamine was the intervention in 14 studies, and ketamine was used in 7 studies. In subgroup analysis, both ketamine and esketamine were significantly effective in reducing the incidence of short-term PPD (ketamine: RR = 0.72, 95% CI [0.56, 0.93], P = 0.01; esketamine: RR = 0.43, P < 0.0001). Esketamine only significantly reduced the incidence of long-term PPD (RR = 0.44, P < 0.00001). Low doses and high doses were effective in reducing the incidence of both short-term (high dose: RR = 0.48, P = 0.0005; low dose: RR = 0.46, P = 0.002) and long-term PPD (high dose: RR = 0.54, P < 0.0001; low dose: RR = 0.61, P = 0.009). Regarding the risk of side effects, patients in the Ketamine/esketamine group showed statistically significant higher rates of developing dizziness (P = 0.0007), blurred vision (P = 0.02), vomiting (P = 0.004) and hallucinations (P = 0,002) than women in the control group. Conclusion: Both ketamine and esketamine are effective in lowering the incidence of short-term PPD. On the other hand, only esketamine is effective in reducing the incidence of long-term PPD. It is recommended to use smaller doses for a more tolerable treatment period since doses less than 0.5 mg are significantly effective. Temporary side effects such as dizziness, blurred vision, vomiting and hallucinations were reported.